-
1
-
-
0030988391
-
The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures
-
Abdulghani A. S., Attwell P. J. E., Bradford H. F. The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures. Eur. J. Pharmacol. 326:1997;7-14.
-
(1997)
Eur. J. Pharmacol.
, vol.326
, pp. 7-14
-
-
Abdulghani, A.S.1
Attwell, P.J.E.2
Bradford, H.F.3
-
2
-
-
0027379927
-
Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: A quantitative autoradiographic study
-
Angelatou F., Pagonopoulou O., Maraziotis T., Olivier A., Villemeure J. G., Avoli M., Kostopoulos G. Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: A quantitative autoradiographic study. Neurosci. Lett. 163:1993;11-14.
-
(1993)
Neurosci. Lett.
, vol.163
, pp. 11-14
-
-
Angelatou, F.1
Pagonopoulou, O.2
Maraziotis, T.3
Olivier, A.4
Villemeure, J.G.5
Avoli, M.6
Kostopoulos, G.7
-
3
-
-
0022965064
-
Adenosine: The brain's natural anticonvulsant
-
Dragunow M. Adenosine: The brain's natural anticonvulsant. Trends Pharmacol. Sci. 7:1986;128.
-
(1986)
Trends Pharmacol. Sci.
, vol.7
, pp. 128
-
-
Dragunow, M.1
-
4
-
-
0023902706
-
Purinergic mechanisms in epilepsy
-
Dragunow M. Purinergic mechanisms in epilepsy. Prog. Neurobiol. 31:1988;85-108.
-
(1988)
Prog. Neurobiol.
, vol.31
, pp. 85-108
-
-
Dragunow, M.1
-
5
-
-
0028351091
-
Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses
-
Dunwiddie T. V., Diao L. Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses. J. Pharmacol. Exp. Ther. 268:1994;537-545.
-
(1994)
J. Pharmacol. Exp. Ther.
, vol.268
, pp. 537-545
-
-
Dunwiddie, T.V.1
Diao, L.2
-
6
-
-
0020072995
-
Sedative and anticonvulsant effects of adenosine analogs in mouse and rat
-
Dunwiddie T. V., Worth T. Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J. Pharmacol. Exp. Ther. 220:1982;70-76.
-
(1982)
J. Pharmacol. Exp. Ther.
, vol.220
, pp. 70-76
-
-
Dunwiddie, T.V.1
Worth, T.2
-
7
-
-
0026459032
-
Adenosine: A potential mediator of seizure arrest and postictal refractoriness
-
During M. J., Spencer D. D. Adenosine: A potential mediator of seizure arrest and postictal refractoriness. Ann. Neurol. 32:1992;618-624.
-
(1992)
Ann. Neurol.
, vol.32
, pp. 618-624
-
-
During, M.J.1
Spencer, D.D.2
-
8
-
-
0032557891
-
Lower density of A1 adenosine receptors in nucleus reticularis thalami in rats with genetic absence epilepsy
-
Ekonomou A., Angelatou F., Vergnes M., Kostopoulos G. Lower density of A1 adenosine receptors in nucleus reticularis thalami in rats with genetic absence epilepsy. Neuroreport. 9:1998;2135-2140.
-
(1998)
Neuroreport
, vol.9
, pp. 2135-2140
-
-
Ekonomou, A.1
Angelatou, F.2
Vergnes, M.3
Kostopoulos, G.4
-
9
-
-
0031843242
-
Seizure prediction by nonlinear time series analysis of brain electrical activity
-
Elger C. E., Lehnertz K. Seizure prediction by nonlinear time series analysis of brain electrical activity. Eur. J. Neurosci. 10:1998;786-789.
-
(1998)
Eur. J. Neurosci.
, vol.10
, pp. 786-789
-
-
Elger, C.E.1
Lehnertz, K.2
-
10
-
-
4243605860
-
Adenosine receptors in the central nervous system
-
Fredholm B. B. Adenosine receptors in the central nervous system. NIPS. 10:1995;122-128.
-
(1995)
NIPS
, vol.10
, pp. 122-128
-
-
Fredholm, B.B.1
-
11
-
-
33845216127
-
Adenosine and neuroprotection
-
Fredholm B. B. Adenosine and neuroprotection. Int. Rev. Neurobiol. 40:1997;259-280.
-
(1997)
Int. Rev. Neurobiol.
, vol.40
, pp. 259-280
-
-
Fredholm, B.B.1
-
12
-
-
0029882167
-
Loss of A1 adenosine receptors in human temporal lobe epilepsy
-
Glass M., Faull R. L. M., Bullock J. Y., Jansen K., Mee E. W., Walker E. B., Synek B. J. L., Dragunow M. Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res. 710:1996;56-68.
-
(1996)
Brain Res.
, vol.710
, pp. 56-68
-
-
Glass, M.1
Faull, R.L.M.2
Bullock, J.Y.3
Jansen, K.4
Mee, E.W.5
Walker, E.B.6
Synek, B.J.L.7
Dragunow, M.8
-
13
-
-
0028910631
-
Involvement of bidirectional adenosine transporters in the release of L-(3H)adenosine from rat brain synaptosomal preparations
-
Gu J. G., Foga I. O., Parkinson F. E., Geiger J. D. Involvement of bidirectional adenosine transporters in the release of L-(3H)adenosine from rat brain synaptosomal preparations. J. Neurochem. 64:1995;2105-2110.
-
(1995)
J. Neurochem.
, vol.64
, pp. 2105-2110
-
-
Gu, J.G.1
Foga, I.O.2
Parkinson, F.E.3
Geiger, J.D.4
-
14
-
-
0029802956
-
Adenosine and the nervous system: Clinical implications
-
Guieu R., Couraud F., Pouget J., Sampieri F., Bechis G., Rochat H. Adenosine and the nervous system: Clinical implications. Clin. Neuropharmacol. 19:1996;459-474.
-
(1996)
Clin. Neuropharmacol.
, vol.19
, pp. 459-474
-
-
Guieu, R.1
Couraud, F.2
Pouget, J.3
Sampieri, F.4
Bechis, G.5
Rochat, H.6
-
15
-
-
0032189155
-
Adenosine and the nervous system: Pharmacological data and therapeutic perspectives
-
Guieu R., Dussol B., Halimi G., Bechis G., Sampieri F., Berland Y., Sampol J., Couraud F., Rochat H. Adenosine and the nervous system: Pharmacological data and therapeutic perspectives. Gen. Pharmacol. 31:1998;553-561.
-
(1998)
Gen. Pharmacol.
, vol.31
, pp. 553-561
-
-
Guieu, R.1
Dussol, B.2
Halimi, G.3
Bechis, G.4
Sampieri, F.5
Berland, Y.6
Sampol, J.7
Couraud, F.8
Rochat, H.9
-
16
-
-
0025115891
-
NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion
-
Hoffmann D., Wahlberg L., Aebischer P. NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion. Exp. Neurol. 110:1990;39-44.
-
(1990)
Exp. Neurol.
, vol.110
, pp. 39-44
-
-
Hoffmann, D.1
Wahlberg, L.2
Aebischer, P.3
-
17
-
-
0002027272
-
Development of selective purinoceptor agonists and antagonists
-
K. A. Jacobson, & M. F. Jarvis. New York: Wiley-Liss
-
Jacobson K. A., van Rhee A. M. Development of selective purinoceptor agonists and antagonists. Jacobson K. A., Jarvis M. F. Purinergic Approaches in Experimental Therapeutics. 1997;101-128 Wiley-Liss, New York.
-
(1997)
Purinergic Approaches in Experimental Therapeutics
, pp. 101-128
-
-
Jacobson, K.A.1
Van Rhee, A.M.2
-
18
-
-
0022351798
-
Kindling with rapidly recurring hippocampal seizures
-
Lothman E. W., Hatfield J. M., Zorumski C. F., Conry J. A., Moon P. F., Perlin J. B. Kindling with rapidly recurring hippocampal seizures. Brain Res. 360:1985;83-91.
-
(1985)
Brain Res.
, vol.360
, pp. 83-91
-
-
Lothman, E.W.1
Hatfield, J.M.2
Zorumski, C.F.3
Conry, J.A.4
Moon, P.F.5
Perlin, J.B.6
-
19
-
-
0021889272
-
The kindling model of epilepsy: A critical review
-
McNamara J. O., Bonhaus D. W., Shin C., Crain B. J., Gellman R. L., Giacchino J. L. The kindling model of epilepsy: A critical review. CRC Crit. Rev. Neurobiol. 1:1985;341-391.
-
(1985)
CRC Crit. Rev. Neurobiol.
, vol.1
, pp. 341-391
-
-
McNamara, J.O.1
Bonhaus, D.W.2
Shin, C.3
Crain, B.J.4
Gellman, R.L.5
Giacchino, J.L.6
-
20
-
-
0022415848
-
Purinergic modulation of the seizure threshold for pentylenetetrazol in the rat
-
Murray T. F., Sylvester D., Schultz C. S., Szot P. Purinergic modulation of the seizure threshold for pentylenetetrazol in the rat. Neuropharmacol. 24:1985;761-766.
-
(1985)
Neuropharmacol.
, vol.24
, pp. 761-766
-
-
Murray, T.F.1
Sylvester, D.2
Schultz, C.S.3
Szot, P.4
-
21
-
-
0027935403
-
Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices
-
Pak M. A., Haas H. L., Decking U. K. M., Schrader J. Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacol. 33:1994;1049-1053.
-
(1994)
Neuropharmacol.
, vol.33
, pp. 1049-1053
-
-
Pak, M.A.1
Haas, H.L.2
Decking, U.K.M.3
Schrader, J.4
-
23
-
-
0018010923
-
Kindling: The first decade
-
Racine R. Kindling: The first decade. Neurosurg. 3:1978;234-252.
-
(1978)
Neurosurg.
, vol.3
, pp. 234-252
-
-
Racine, R.1
-
24
-
-
0023611674
-
Differential effects of adenosine analogs on amygdala, hippocampus, and caudate nucleus kindled seizures
-
Rosen J. B., Berman R. F. Differential effects of adenosine analogs on amygdala, hippocampus, and caudate nucleus kindled seizures. Epilepsia. 28:1987;658-666.
-
(1987)
Epilepsia
, vol.28
, pp. 658-666
-
-
Rosen, J.B.1
Berman, R.F.2
-
26
-
-
0029954486
-
The epidemiology and treatment of chronic and refractory epilepsy
-
Shorvon S. D. The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia. 37:1996;S1-S3.
-
(1996)
Epilepsia
, vol.37
-
-
Shorvon, S.D.1
-
27
-
-
0028172129
-
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy
-
Simonato M., Varani K., Muzzolini A., Bianchi C., Beani L., Borea P. A. Adenosine A1 receptors in the rat brain in the kindling model of epilepsy. Eur. J. Pharmacol. 265:1994;121-124.
-
(1994)
Eur. J. Pharmacol.
, vol.265
, pp. 121-124
-
-
Simonato, M.1
Varani, K.2
Muzzolini, A.3
Bianchi, C.4
Beani, L.5
Borea, P.A.6
-
29
-
-
0028258190
-
2+ channels in supporting hippocampal synaptic transmission
-
2+ channels in supporting hippocampal synaptic transmission. Science. 264:1994;107-111.
-
(1994)
Science
, vol.264
, pp. 107-111
-
-
Wheeler, D.B.1
Randall, A.2
Tsien, R.W.3
-
30
-
-
0024433446
-
An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats
-
Winn S. R., Wahlberg L., Tresco P. A., Aebischer P. An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats. Exp. Neurol. 105:1989;244-250.
-
(1989)
Exp. Neurol.
, vol.105
, pp. 244-250
-
-
Winn, S.R.1
Wahlberg, L.2
Tresco, P.A.3
Aebischer, P.4
|